NB1011
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NB1011, covering 2013-12-18 to 2022-05-16. Get the full timeline:
Most recent: Clinical Trial Update: NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS) [Phase 1, Phase 2]